This service is an advanced genetic test that analyses 17 genes known to significantly increase an individual’s risk of developing hereditary breast, gynaecological and colorectal cancer, including Polygenic Risk Scores, providing information about a patient’s risk of common multifactorial diseases.

• Whole genome sequencing technology and analysis with CE-IVD software.
• Analysis of thousands to millions of variants related to the conditions tested.
• Possibility of extending the assay to other conditions as the science advances.
• Access to Poligenic risk calculators to assess the absolute risk based on genetic and clinical factors.